Authors:
SCAVINI M
GALLI L
REICH S
EATON RP
CHARLES MA
DUNN FL
MICOSSI P
TORRI M
PETRELLA G
GALIMBERTI G
CRISTALLO M
VAI S
POZZA G
OLSEN C
TURNER D
NOLLEMAN C
LAVINTOMPKINS J
SELAM JL
HAARDT MJ
DORANGE C
JEANDIDIER N
ORTEGA F
BOIVIN S
NATHAN D
LARKIN M
MCKITRICK C
SCHWARZ S
FISHER J
KIPNES S
WALZ B
VAGUE P
REEVES ML
GOUDNER M
THOMSON GP
JAFFIOL C
RENARD E
LAUTON D
JACQUESAPOSTOL D
BRINGER J
TAUBER JP
HANAIREBROUTIN H
REESJONES R
ADOLFF S
BAYS HA
PFEIFER M
CLARKE D
IRSIGLER K
FEINBOCH C
HUTTER R
MENDEL H
DIGLAS J
Citation: M. Scavini et al., CATHETER SURVIVAL DURING LONG-TERM INSULIN THERAPY WITH AN IMPLANTED PROGRAMMABLE PUMP, Diabetes care, 20(4), 1997, pp. 610-613
Authors:
PINGET M
JEANDIDIER N
ORTEGA F
WIX D
MARGETAUX J
FEINBOCK C
DIGLAS J
MENDL H
IRSIGLER K
SCAVINI M
PETRELLA G
TORRI M
CRISTALLO M
POZZA G
LUDDEKE HJ
GROTH T
RENNER R
HEPP KD
SELAM JL
HAARDT MJ
BETHOUX JP
DORANGE C
SLAMA G
VAGUE P
LASSMANVAGUE V
BELICAR P
JOHANSSON M
HAMMARBERG B
FAHLSTROM U
BASELIUS L
SJOHOLM G
Citation: M. Pinget et al., MULTICENTER TRIAL OF A PROGRAMMABLE IMPLANTABLE INSULIN PUMP IN TYPE-I DIABETES, International journal of artificial organs, 18(6), 1995, pp. 322-325
Authors:
HAARDT MJ
SELAM JL
SLAMA G
BETHOUX JP
DORANGE C
MACE B
RAMANICHE ML
BRUZZO F
Citation: Mj. Haardt et al., A COST-BENEFIT COMPARISON OF INTENSIVE DIABETES MANAGEMENT WITH IMPLANTABLE PUMPS VERSUS MULTIPLE SUBCUTANEOUS INJECTIONS IN PATIENTS WITH TYPE-I DIABETES, Diabetes care, 17(8), 1994, pp. 847-851
Authors:
SELAM JL
HAARDT MJ
BERNE C
DORANGE C
LANOE JL
BETHOUX JP
SLAMA G
Citation: Jl. Selam et al., COST-BENEFITS OF INTENSIVE INSULIN THERAP Y WITH EXTERNAL OR IMPLANTABLE PUMPS VS SUBCUTANEOUS INJECTIONS, Diabete et metabolisme, 19(5BIS), 1993, pp. 506-509